ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

“We’re All Filling Up With Carcinogens” Ames Tells NCAB

October 7, 1977

Also in this 8-page issue: Intel Chairman Andrew Grove slams NCI director and cancer program for “wishful dreams” and “chemo speeches,” recommends moratorium on funding for cancer research.

May 14, 2004

In Brief: Jensen, Selikoff Receive ACS National Awards; CCIRC Schedules Mini-Symposium

October 22, 1976

Tight Budget, Turf Battles Kill One Project, Threaten Popular CGP Clinical Trials Effort

July 4, 1986

Senate Appropriations Report Language On NCI, NIH Budgets

September 20, 1996

In Brief: Columiba Adds Presbyterian to Center’s Name: Clinton’s Mother Honored; DeVita move Rumored

March 5, 1993